Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-27
2007-03-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S370000, C546S269700
Reexamination Certificate
active
10631423
ABSTRACT:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
REFERENCES:
patent: 4260765 (1981-04-01), Harrison et al.
patent: 4908375 (1990-03-01), Lambert et al.
patent: 5041426 (1991-08-01), Robins et al.
patent: 5208248 (1993-05-01), Baker et al.
patent: 5294596 (1994-03-01), Haas et al.
patent: 5364871 (1994-11-01), Takasugi et al.
patent: 5395818 (1995-03-01), Haas et al.
patent: 5614518 (1997-03-01), Leeson et al.
patent: 5679674 (1997-10-01), Terada et al.
patent: 5693667 (1997-12-01), Phillion et al.
patent: 5821245 (1998-10-01), Howard, Jr.
patent: 5945380 (1999-08-01), Gallenkamp et al.
patent: 4204 452 (1992-08-01), None
patent: 4204492 (1992-08-01), None
patent: 0 438 230 (1991-07-01), None
patent: 0 468 695 (1991-07-01), None
patent: 0 761 658 (1997-03-01), None
patent: 0 911 634 (1999-04-01), None
patent: 2155856 (1973-05-01), None
patent: 1 437 895 (1976-06-01), None
patent: 2 263 109 (1993-07-01), None
patent: 2 293 380 (1996-03-01), None
patent: 1 437 895 (1976-06-01), None
patent: WO 89/00568 (1989-01-01), None
patent: WO 96/23783 (1996-08-01), None
patent: WO 97/01552 (1997-01-01), None
patent: WO 97/21707 (1997-06-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 98/57969 (1998-12-01), None
patent: WO 99/00357 (1999-01-01), None
patent: WO 99/21555 (1999-05-01), None
patent: WO 99/23091 (1999-05-01), None
patent: WO 99/24416 (1999-05-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32110 (1999-07-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 99/32436 (1999-07-01), None
patent: WO 99/32455 (1999-07-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 99/46244 (1999-09-01), None
patent: WO 99/58502 (1999-11-01), None
patent: WO 99/65884 (1999-12-01), None
patent: WO 00/21926 (2000-04-01), None
patent: WO 00/24735 (2000-05-01), None
patent: WO 00/24739 (2000-05-01), None
patent: WO 00/26203 (2000-05-01), None
patent: WO 00/35455 (2000-06-01), None
patent: WO 00/56681 (2000-09-01), None
patent: WO 01/36403 (2001-05-01), None
patent: WO 02/14311 (2002-02-01), None
Maccioni et al., “The protein kinase Cdk5 Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology” Eur. J. Biochem., 268;1518-1527 (2001).
Noguchi et al., “Involvement of Cyclins in Cell Proliferation and Their Clinical Implications in Soft Tissue Smooth Muscle Tumors.” Amer. J. of Pathology, 156:6, 2135-2147 (2000).
Paglini et al., “The role of the Cdk5-p35 kinase in neuronal development.” Eur. J. Biochem., 268: 1528-1533 (2001).
Senderowicz et al., “Preclinical and Clinical development of cyclin-dependent kinase modulators.” J. of the Natl. Cancer Inst., 92:5, 376-387 (2000).
EP Search Report for EP 05 01 5480 (5 pages) (2005).
Abstract Vasilev et al.,Frziol. Rast.(Sofia), vol. 15, No. 4, pp. 47-54 (1989).
Abstract Novikov et al.,Zh. Priki. Khim.(Leningrad), vol. 42, No. 10, pp. 2373-2377 (1969).
Abstract Acheson, R. et al,J. Chem. Res., Synop., No. 10, 333 pages (1979).
Abstract Foks et al.,Acta Pol. Pharm., vol. 35, No. 5, pp. 615-618 (1978).
Database Z Registry No. 200134-28-7 (2001).
Database Z Registry No. 197228-26-5 (1972).
Askew, Jr. Benny C.
De Morin Frenel F.
Hague Andrew
Laber Ellen
Li Aiwen
Amgen Inc.
Banner & Witcoff
Saeed Kamal A.
LandOfFree
Thiazolyl urea compounds and methods of uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolyl urea compounds and methods of uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolyl urea compounds and methods of uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3723448